Guardian Pharmacy Services, Inc. (GRDN) Stock Score, Valuation & Financial Research
Guardian Pharmacy Services, Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 47/100.
Quick answer for GRDN
Guardian Pharmacy Services, Inc. currently has a Wall Street Score of 47/100. The stored market price is $43.64. Its financial score is 37/100. Its valuation score is 0/100. The latest WSS change is +0.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What Guardian Pharmacy Services, Inc. does
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermo
GRDN financial snapshot
- Wall Street Score:
- 47/100
- Current price:
- $43.64
- Market capitalization:
- $2.76B
- Revenue:
- $1.46B
- Net income:
- $65.9M
- Free cash flow:
- $80.7M
- Cash:
- $89.8M
- Total debt:
- $35.2M
- EPS:
- 0.79
- P/E ratio:
- 55.2x
- Financial score:
- 37/100
- Valuation score:
- 0/100
- Revenue score:
- 26/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $80.7M, showing positive cash generation.
- The balance sheet shows $89.8M of cash versus $35.2M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.5 points: GRDN increased 0.5 points because Capital improved by 5 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 37/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research GRDN
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.